BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2156717)

  • 1. Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity.
    Hansen SH; Behrendt N; Danø K; Kristensen P
    Exp Cell Res; 1990 Apr; 187(2):255-62. PubMed ID: 2156717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
    Behrendt N; Rønne E; Ploug M; Petri T; Løber D; Nielsen LS; Schleuning WD; Blasi F; Appella E; Danø K
    J Biol Chem; 1990 Apr; 265(11):6453-60. PubMed ID: 2156852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.
    Schmitt M; Chucholowski N; Busch E; Hellmann D; Wagner B; Goretzki L; Jänicke F; Günzler WA; Graeff H
    Semin Thromb Hemost; 1991 Jul; 17(3):291-302. PubMed ID: 1724574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
    Nielsen LS; Kellerman GM; Behrendt N; Picone R; Danø K; Blasi F
    J Biol Chem; 1988 Feb; 263(5):2358-63. PubMed ID: 2828365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils.
    Politis I; Zavizjon B; Cheli F; Baldi A
    J Dairy Res; 2002 May; 69(2):195-204. PubMed ID: 12222798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells.
    Del Rosso M; Pedersen N; Fibbi G; Pucci M; Dini G; Anichini E; Blasi F
    Exp Cell Res; 1992 Dec; 203(2):427-34. PubMed ID: 1333982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
    Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
    Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
    Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
    Wolf BB; Gibson CA; Kapur V; Hussaini IM; Musser JM; Gonias SL
    J Biol Chem; 1994 Dec; 269(48):30682-7. PubMed ID: 7982988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-localization of urokinase and its receptor on established human umbilical vein endothelial cell.
    Ueshima S; Matsumoto H; Izaki S; Mitsui Y; Fukao H; Okada K; Matsuo O
    Cell Struct Funct; 1999 Apr; 24(2):71-8. PubMed ID: 10362070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase synthesis and binding by glomerular epithelial cells in culture.
    Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
    Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
    Genton C; Kruithof EK; Schleuning WD
    J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
    Ellis V; Wun TC; Behrendt N; Rønne E; Danø K
    J Biol Chem; 1990 Jun; 265(17):9904-8. PubMed ID: 2161846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
    Moser TL; Enghild JJ; Pizzo SV; Stack MS
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
    Picone R; Kajtaniak EL; Nielsen LS; Behrendt N; Mastronicola MR; Cubellis MV; Stoppelli MP; Pedersen S; Danø K; Blasi F
    J Cell Biol; 1989 Feb; 108(2):693-702. PubMed ID: 2537321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.
    Heegaard CW; Simonsen AC; Oka K; Kjøller L; Christensen A; Madsen B; Ellgaard L; Chan L; Andreasen PA
    J Biol Chem; 1995 Sep; 270(35):20855-61. PubMed ID: 7657671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.